Introduction: The non-adherence to therapy of diabetics is grafted with heavy morbidity and mortality. Our study aims to determine the factors of non-adherence with antidiabetic drugs in type 2 diabetics. Methods: This was a descriptive and analytical cross-sectional study, carried out in the Endocrinology Unit of the Joseph Raseta University Hospital Center. Befelatanana, Antananarivo, over a period of 7 months. Adherence to treatment was assessed by the Morisky scale. Results: We retained 104 patients with an average age of 58.36 years, consisting of 52.88% of women. Adherence was high, medium, and low in 6.73%, 31.73% and 61.54% of cases, respectively. From their attending physician, explanations of the diabetic disease and their treatment were received by 90.38% and 66.35% of patients, respectively. However, these patients were aware of their disease and treatment in 18.27% and 41.35% of cases, respectively. The most observed non-adherence factors were the absence of an appointment given by the physician (30.77%), the feeling of well-being (24.04%), the lack of money (21.15%), forgetting (20.19%) and advice from a traditional practitioner (16.35%). Only the doctor's explanation for diabetes treatment was significantly associated with medication nonadherence (p=0.0310). Conclusion: Continuing medical education for physician is essential so that they can strengthen therapeutic education and follow-up for their diabetics.
| Published in | International Journal of Diabetes and Endocrinology (Volume 6, Issue 4) |
| DOI | 10.11648/j.ijde.20210604.11 |
| Page(s) | 125-130 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
Antidiabetic Drugs, Diabetes Mellitus, Madagascar, Morisky Score, Non-adherence
| [1] | Balakumar P, Maung-UK, Jagadeesh G. (2016). Prevalence and prevention of cardiovascular disease and diabetes mellitus. Pharmacol Res, 113 (Pt A): 600-9.4. |
| [2] | World Health Organization. (2003). Adherence to long-term therapies: evidence for action / [edited by Eduardo Sabaté]. World Health Organization. https://apps.who.int/iris/handle/10665/42682. |
| [3] | Kurtz SM. (1990). Adherence to Diabetes Regimens: Empirical Status and Clinical Applications. Diabetes Educ, 16 (1): 50-9. |
| [4] | Sanogo S, Diallo MM, Niantao A, Diallo AM, Lokrou A. (2013). Therapeutic compliance of type 2 diabetic patients on oral antidiabetics at the Gabriel Toure University Hospital in Mali. Diabetes Metab, 39 (1): A113. |
| [5] | Tieno H, Bouda M, Ouedraogo DD, Traore R, Ouedraogo C, Drabo YJ. (2010). Observance to antidiabetic treatment in a developing country: The case in Burkina Faso (sub-Saharan Africa). Médecine des maladies Métaboliques, 4 (2): 207-11. |
| [6] | Raimi TH. (2017). Factors influencing medication adherence among patients with Diabetes mellitus and Hypertension in Nigeria. European Journal of Biology and Medical Science Research, 5 (7): 18-26. |
| [7] | American Diabetes Association. (2018). Standards of medical Care in diabetes – 2018. Diabetes Care; 41 (1): S1-S159. |
| [8] | Morisky DE, Ang A, Krousel-Wood M, Ward HJ. (2008). Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich), 10 (5): 348-54. |
| [9] | Morisky DE, Green LW, Levine DM. (1986). Concurrent and predictive validity of a self-reported medication adherence. Med Care, 24 (1): 67-74. |
| [10] | Morisky DE, Ang A, Krousel-Wood M, Ward HJ. (2002). Predictive validity of a self-reported medication adherence. Med Care, 25: 1015-21. |
| [11] | Mahfouz EM, Awadalla HI. (2011). Compliance to diabetes self-management in rural El-Minia, Egypt. Cent Eur J Public Health, 19 (1): 35–41. |
| [12] | Mukherjee S, Sharmasarkar B, Das KK, Bhattacharyya A, Deb A. (2013). Compliance to anti-diabetic drugs: observations from the diabetic clinic of a medical college in kolkata, India. J Clin Diagn Res, 7 (4): 661-665. |
| [13] | Khan AR, Al-Abdul Lateef ZN, Al Aithan MA, Bu-Khamseen MA, Al Ibrahim I, Khan SA. (2012). Factors contributing to non-compliance among diabetics attending primary health centers in the Al Hasa district of Saudi Arabia. J Family Community Med, 19 (1): 26-32. |
| [14] | Mosnier-Pudar H, Hochberg G, Eschwege E, Virally ML, Halimi S, Guillausseau PJ et al. (2009). How do patients with type 2 diabetes perceive their disease? Insights from the French DIABASIS survey. Diabetes Metab, 35 (3): 220-7. |
| [15] | Khotkar K, Chaudhari S, Jadhav PR, Deshmukh Y, Kaul S, Puri C. (2017). Assessment of Medication Adherence in Type II Diabetic Patients: A Cross-sectional Study. Journal of the Medical Sciences, 4: 65-69. |
| [16] | Tiv M, Viel JF, Mauny F, Eschwège E, Weill A, Fournier C, et al. (2012). Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based Study. PLoS One, 7 (3): e32412. |
| [17] | Bruce SP, Acheampong F, Kretchy I. (2015). Adherence to oral anti-diabetic drugs among patients attending a Ghanaian teaching hospital. Pharma Pract, 13 (1): 533. |
| [18] | Gimenes HT, Zanetti ML, Haas VJ. (2009). Factors related to patient adherence to antidiabetic drug therapy. Rev Lat Am Enfermagem, 17 (1): 46-51. |
| [19] | Detournay B, Cros S, Charbonnel B, Grimaldi A, Liard F, Cogneau J, et al. (2000). Managing type 2 diabetes in France: the ECODIA survey. Diabetes Metab, 26 (5): 363-9. |
| [20] | Elsous A, Radwan M, Al-Sharif H, Abu Mustafa A. (2017). Medications Adherence and Associated Factors among Patients with Type 2 Diabetes Mellitus in the Gaza Strip, Palestine. Front Endocrinol (Lausanne), 8: 100. |
| [21] | Lastra G, Syed S, Kurukulasuriya LR, Manrique C, Sowers JR. (2014). Type 2 diabetes mellitus and hypertension: an update. Endocrinol Metab Clin North Am, 43 (1): 103-122. |
| [22] | Schectman JM, Nadkarni MM, Voss JD. (2002). The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care, 25 (6): 1015-21. |
| [23] | Dailey G, Kim MS, Lian JF. (2002). Patient compliance and persistence with anti-hyperglycemic therapy: evaluation of a population of type 2 diabetic patients. J Int Med Res, 30 (1): 71-9. |
| [24] | Lawson VL, Lyne PA, Harvey JN, Bundy CE. (2005). Understanding why people with type 1 diabetes do not attend for specialist advice: a qualitative analysis of the views of people with insulin-dependent diabetes who do not attend diabetes clinic. J Health Psychol, 10 (3): 409-23. |
| [25] | Mense K, Mapatano MA, Mutombo PB, Muyer MC. (2014). A case-control study to determine the sources of noncompliance to medical monitoring in diabetic patients in Kinshasa in 2010. Pan Afr Med J, 8; 17: 258. French. |
| [26] | Sajith M, Pankaj M, Pawar A, Modi A, Sumariya R. (2014). Medication adherence to antidiabetic therapy in patients with type 2 diabetes mellitus. Int J Pharm Pharm Sci, 6 (2): 564-570. |
| [27] | Bagonza J, Rutebemberwa E, Bazeyo W. (2015). Adherence to anti diabetic medication among patients with diabetes in eastern Uganda; a cross sectional study. BMC Health Serv Res, 9; 15: 168. |
| [28] | Heissam K, Abuamer Z, El-Dahshan N. (2015). Patterns and obstacles to oral antidiabetic medications adherence among type2 diabetics in Ismailia, Egypt: a cross section stydy. Pan Afr Med J, 20: 177. |
| [29] | Rwegerera GM. (2014). Adherence to anti-diabetic drugs among patients with Type 2 diabetes mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania- A cross-sectional study. Pan Afr Med J, 7; 17: 252. |
APA Style
Sitraka Angelo Raharinavalona, Rija Eric Raherison, Thierry Razanamparany, Solofo Andrianarivelo Ralamboson, Andrinirina Dave Patrick Rakotomalala, et al. (2021). Factors of Non-adherence to Antidiabetic Drugs in Type 2 Diabetics, Antananarivo Madagascar. International Journal of Diabetes and Endocrinology, 6(4), 125-130. https://doi.org/10.11648/j.ijde.20210604.11
ACS Style
Sitraka Angelo Raharinavalona; Rija Eric Raherison; Thierry Razanamparany; Solofo Andrianarivelo Ralamboson; Andrinirina Dave Patrick Rakotomalala, et al. Factors of Non-adherence to Antidiabetic Drugs in Type 2 Diabetics, Antananarivo Madagascar. Int. J. Diabetes Endocrinol. 2021, 6(4), 125-130. doi: 10.11648/j.ijde.20210604.11
AMA Style
Sitraka Angelo Raharinavalona, Rija Eric Raherison, Thierry Razanamparany, Solofo Andrianarivelo Ralamboson, Andrinirina Dave Patrick Rakotomalala, et al. Factors of Non-adherence to Antidiabetic Drugs in Type 2 Diabetics, Antananarivo Madagascar. Int J Diabetes Endocrinol. 2021;6(4):125-130. doi: 10.11648/j.ijde.20210604.11
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ijde.20210604.11,
author = {Sitraka Angelo Raharinavalona and Rija Eric Raherison and Thierry Razanamparany and Solofo Andrianarivelo Ralamboson and Andrinirina Dave Patrick Rakotomalala and Hanta Marie Danielle Vololontiana and Radonirina Lazasoa Andrianasolo},
title = {Factors of Non-adherence to Antidiabetic Drugs in Type 2 Diabetics, Antananarivo Madagascar},
journal = {International Journal of Diabetes and Endocrinology},
volume = {6},
number = {4},
pages = {125-130},
doi = {10.11648/j.ijde.20210604.11},
url = {https://doi.org/10.11648/j.ijde.20210604.11},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijde.20210604.11},
abstract = {Introduction: The non-adherence to therapy of diabetics is grafted with heavy morbidity and mortality. Our study aims to determine the factors of non-adherence with antidiabetic drugs in type 2 diabetics. Methods: This was a descriptive and analytical cross-sectional study, carried out in the Endocrinology Unit of the Joseph Raseta University Hospital Center. Befelatanana, Antananarivo, over a period of 7 months. Adherence to treatment was assessed by the Morisky scale. Results: We retained 104 patients with an average age of 58.36 years, consisting of 52.88% of women. Adherence was high, medium, and low in 6.73%, 31.73% and 61.54% of cases, respectively. From their attending physician, explanations of the diabetic disease and their treatment were received by 90.38% and 66.35% of patients, respectively. However, these patients were aware of their disease and treatment in 18.27% and 41.35% of cases, respectively. The most observed non-adherence factors were the absence of an appointment given by the physician (30.77%), the feeling of well-being (24.04%), the lack of money (21.15%), forgetting (20.19%) and advice from a traditional practitioner (16.35%). Only the doctor's explanation for diabetes treatment was significantly associated with medication nonadherence (p=0.0310). Conclusion: Continuing medical education for physician is essential so that they can strengthen therapeutic education and follow-up for their diabetics.},
year = {2021}
}
TY - JOUR T1 - Factors of Non-adherence to Antidiabetic Drugs in Type 2 Diabetics, Antananarivo Madagascar AU - Sitraka Angelo Raharinavalona AU - Rija Eric Raherison AU - Thierry Razanamparany AU - Solofo Andrianarivelo Ralamboson AU - Andrinirina Dave Patrick Rakotomalala AU - Hanta Marie Danielle Vololontiana AU - Radonirina Lazasoa Andrianasolo Y1 - 2021/10/12 PY - 2021 N1 - https://doi.org/10.11648/j.ijde.20210604.11 DO - 10.11648/j.ijde.20210604.11 T2 - International Journal of Diabetes and Endocrinology JF - International Journal of Diabetes and Endocrinology JO - International Journal of Diabetes and Endocrinology SP - 125 EP - 130 PB - Science Publishing Group SN - 2640-1371 UR - https://doi.org/10.11648/j.ijde.20210604.11 AB - Introduction: The non-adherence to therapy of diabetics is grafted with heavy morbidity and mortality. Our study aims to determine the factors of non-adherence with antidiabetic drugs in type 2 diabetics. Methods: This was a descriptive and analytical cross-sectional study, carried out in the Endocrinology Unit of the Joseph Raseta University Hospital Center. Befelatanana, Antananarivo, over a period of 7 months. Adherence to treatment was assessed by the Morisky scale. Results: We retained 104 patients with an average age of 58.36 years, consisting of 52.88% of women. Adherence was high, medium, and low in 6.73%, 31.73% and 61.54% of cases, respectively. From their attending physician, explanations of the diabetic disease and their treatment were received by 90.38% and 66.35% of patients, respectively. However, these patients were aware of their disease and treatment in 18.27% and 41.35% of cases, respectively. The most observed non-adherence factors were the absence of an appointment given by the physician (30.77%), the feeling of well-being (24.04%), the lack of money (21.15%), forgetting (20.19%) and advice from a traditional practitioner (16.35%). Only the doctor's explanation for diabetes treatment was significantly associated with medication nonadherence (p=0.0310). Conclusion: Continuing medical education for physician is essential so that they can strengthen therapeutic education and follow-up for their diabetics. VL - 6 IS - 4 ER -
Information
Email: